News

株式会社４DINは、本研究の運営管理、進捗管理として本研究に参画いたしました

■論文表題
Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy

https://doi.org/10.1111/1756-185X.14695

■書誌情報
Noboru Kitamura1 | Hitomi Kobayashi1 | Yosuke Nagasawa1 | Kaita Sugiyama1 | Hiroshi Tsuzuki1 | Yutaka Tanikawa1 | Natsumi Ikumi2 | Yuito Okada3 | Yasuo Takahashi3 | Satoshi Asai4 | Naoto Tamura5 | Michihiro Ogasawara5 | Toshio Kawamoto5 | Ryohei Kuwatsuru6 | Hiromichi Tamaki7 | Genki Kidoguchi7 | Mutsuto Tateishi8 | Makiko Kimura8 | Yuichi Mochida9 | Kengo Harigane9 | Takayuki Shimazaki9 | Takao Koike10 | Kazuhide Tanimura10 | Hiroshi Kataoka11 | Koichi Amano12 | Hidekata Yasuoka13 | Masami Takei1

1 Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
2 Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan
3 Clinical Trials Research Center, Nihon University School of Medicine, Tokyo, Japan
4 Department of Pharmacology and Biofunction Medicine, Nihon University School of Medicine, Tokyo, Japan
5 Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan
6 Department of Radiology & Center for Promotion of Data Science, Juntendo University Graduate School of Medicine, Tokyo, Japan
7 Immuno-Rheumatology Center, St. Luke’s International Hospital, Tokyo, Japan
8 Department of Rheumatology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan
9 Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan
10Hokkaido Medical Center for Rheumatic Diseases, Sapporo, Japan
11 Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Sapporo, Japan
12 Department of Rheumatology and Clinical Immunology, Saitama Medical Center Saitama Medical University, Saitama, Japan
13 Department of Internal Medicine, Division of Rheumatology, Fujita Health University School of Medicine, Toyoake, Japan